Reduced Risk Of Heart Attack, Stroke, Death Observed In Long Term Use Of 'Brilinta' From AstraZeneca

March 15, 2015 1:15 PM

3 0

AstraZeneca's new drug Brilinta can significantly reduce the chances of another stroke, heart attack and even death itself after a clinical trial on Saturday.

AstraZeneca's new drug Brilinta can significantly reduce the chances of another stroke, heart attack and even death itself after a clinical trial on Saturday.

Also read: Najdawi scores 30 to lead The Citadel past Colgate 108-101

Read more

To category page

Loading...